A5 Template Masters
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
Brochure Title Here<br />
2. Medical products and medical<br />
devices - An overview of their<br />
regulation in Europe<br />
An overview of their regulation in Europe<br />
Under European legislation, a medicinal product is defined as any substance<br />
or combination of substances presented for treating or preventing disease<br />
in human beings. This includes combinations of substances that may be<br />
administered to human beings to make a medical diagnosis or to restore,<br />
correct or modify their physiological functions.<br />
We also acted on the first reported<br />
case of HMRC using Schedule 36 of<br />
the Finance Act 2008 to btain<br />
In the landmark case of Pyrrho<br />
Investments v MWB Property & Ors<br />
[ 2016 ] EWHC 256 (Ch), the team<br />
obtained the English court’s first<br />
express approval of the use of<br />
Predictive Coding in disclosure – in<br />
which the court recognised the<br />
significant time and costs benefits<br />
that could be gained from using<br />
this technology<br />
We have partnered with an AI<br />
start-up (LitiGate) to assist with<br />
their product development which<br />
seeks to streamline and optimise<br />
legal research, initially in relation<br />
to interim applications<br />
Ed Spencer, one of our Senior<br />
Associates, is heavily involved with<br />
Relativity (formerly kCura) in both<br />
London and Chicago regularly<br />
participating in user development<br />
workshops and product feedback<br />
sessions. He is a regular speaker<br />
at eDisclosure and information<br />
governance conferences around<br />
the world where he presents on the<br />
latest igations.<br />
2. Medicinal products<br />
and medical devices<br />
An overview of their regulation in Europe<br />
We also acted on the first reported<br />
case of HMRC using Schedule 36 of<br />
the Finance Act 2008 to btain<br />
In the landmark case of Pyrrho<br />
Investments v MWB Property & Ors<br />
[ 2016 ] EWHC 256 (Ch), the team<br />
obtained the English court’s first<br />
express approval of the use of<br />
Predictive Coding in disclosure – in<br />
which the court recognised the<br />
significant time and costs benefits<br />
that could be gained from using<br />
this technology<br />
We have partnered with an AI<br />
start-up (LitiGate) to assist with<br />
Chapter Title<br />
Under European legislation, a medicinal product is defined as any substance<br />
or combination of substances presented for treating or preventing disease<br />
in human beings. This includes combinations of substances that may be<br />
administered to human beings to make a medical diagnosis or to restore,<br />
correct or modify their physiological functions.<br />
their product development which<br />
seeks to streamline and optimise<br />
legal research, initially in relation<br />
to interim applications<br />
Ed Spencer, one of our Senior<br />
Associates, is heavily involved with<br />
Relativity (formerly kCura) in both<br />
London and Chicago regularly<br />
participating in user development<br />
workshops and product feedback<br />
sessions. He is a regular speaker<br />
at eDisclosure and information<br />
governance conferences around<br />
the world where he presents on the<br />
latest igations.<br />
23<br />
24